Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Oct 8, 2021 (Letter of inquiry)

Later deadlines: Nov 8, 2021 (Full proposal)

Grant amount: Unspecified amount

Fields of work: Cancer/Oncology Microbiomes

Applicant type: Government Entity, Indigenous Group, Nonprofit

Funding uses: Non-clinical Biomedical

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE:

  • Applications are due by 5pm submitter's local time. 
  • Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

The purpose of this Funding Opportunity Announcement (FOA) is to support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed March 06, 2019 and last updated March 06, 2019